Control arm: standard support only
During the end of active treatment consultation, the oncologist will prescribe the adjuvant hormone therapy treatment in accordance with multidisciplinary team decision and patient.The SCP will be then given to the patient, presented as a personalized follow-up and medical monitoring program alternating with her general practitioner. The relay with the attending physician will be carried out. The oncologist will then receive patients in consultation at 6 and 18 months after the start of hormone therapy. The patient will be free to discuss any concerns she may have with her attending physician. Information on social and psychological support for the patient or her family will be provided by the breast nurses at the end-of-treatment consultation, supplemented by a brochure entitled “Preparing for Life After Treatment”.The breast nurse who has accompanied the patient throughout her care will remain available by phone or email if necessary.